Taken together, using Avibirnavirus IBDV as a model of a nonenveloped RNA virus, we revealed the fine-tuned regulation mechanism of the conversion between SUMOylation and deSUMOylation of API5 upon virus infection and provided new ideas for the design of anti-IBDV agents. The gene discussed is API5; the disease is viral infectious disease.